Researchers from Belarus and China have announced the successful development of innovative polymer-based nanoparticles designed for advanced cancer treatment, reports
BelTA, a partner of TV BRICS.
The joint research project, conducted by specialists from Belarus’ National Academy of Sciences and their Chinese counterparts in Shanghai, focused on the creation and testing of nanoparticles for use in sonodynamic therapy – a cutting-edge method that combines ultrasound technology with targeted drug delivery.
According to the research findings, the newly engineered nanoparticles demonstrated the ability to selectively accumulate in tumour cells when introduced into the body.
In addition to their direct therapeutic effect, the treatment was found to activate the immune system, enhancing the body’s natural response against malignant tumours. This dual-action mechanism is considered particularly promising for improving the effectiveness of cancer therapies while reducing damage to healthy tissues.
Experts note that further research and clinical trials will be required before the technology can be applied in routine medical practice.